128 related articles for article (PubMed ID: 6170349)
1. [Effect of chemical modification on proteinase interaction with inhibitors, on their coagulability and acute toxicity].
Bogacheva TI; Mirgorodskaia OA; Grinberg GE; Mikhaĭlets GA; Moskvichev BV
Biokhimiia; 1981 May; 46(5):863-71. PubMed ID: 6170349
[TBL] [Abstract][Full Text] [Related]
2. [Interactions between human blood serum inhibitors and native and modified dextran proteinases--terrilytin and trypsin].
Lindenbaum GM; Tereshin IM
Biokhimiia; 1978 Dec; 43(12):2143-9. PubMed ID: 84689
[TBL] [Abstract][Full Text] [Related]
3. [Some physicochemical properties of modified trypsin].
Bogacheva TI; Mirgorodskaia OA; Moskvichev BV
Biokhimiia; 1977 Apr; 42(4):609-15. PubMed ID: 15658
[TBL] [Abstract][Full Text] [Related]
4. [Physico-chemical properties of terrylytin modified by a copolymer based on vinylpyrrolidone].
Tennikova TB; Moskvichev BV; Samsonov GB
Biokhimiia; 1980 Mar; 45(3):438-48. PubMed ID: 6155152
[TBL] [Abstract][Full Text] [Related]
5. The properties of rabbit alpha1-macroglobulin upon activation are distinct from those of rabbit and human alpha2-macroglobulins.
Banbula A; Chang LS; Beyer WF; Bohra CL; Cianciolo GJ; Pizzo SV
J Biochem; 2005 Nov; 138(5):527-37. PubMed ID: 16272565
[TBL] [Abstract][Full Text] [Related]
6. [Effect of proteolytic inhibitors from human plasma on the activity of native and immobilized terrilytin].
Raĭko IE; Karpenko GF
Ukr Biokhim Zh (1978); 1988; 60(1):91-4. PubMed ID: 2452503
[TBL] [Abstract][Full Text] [Related]
7. Removal of trypsin complexed alpha-2 macroglobulin by plasma fractionation.
Nakayama S; Hermann RE; Malchesky PS; Zborowski M; Walsh RM; Sato T
ASAIO J; 1993; 39(3):M297-300. PubMed ID: 7505639
[TBL] [Abstract][Full Text] [Related]
8. Uptake of 125I-labelled alpha2-macroglobulin and albumin by human placental syncytiotrophoblast in vitro.
Douglas GC; Moreira-Cali P; King BF; Lonnerdal B
J Cell Biochem; 1998 Mar; 68(4):427-35. PubMed ID: 9493906
[TBL] [Abstract][Full Text] [Related]
9. [Effect of terrilitin on the proteolytic activity of the blood and formation of an immunostimulating factor by spleen cells].
Prokopenko LG; Chalyĭ GA
Ukr Biokhim Zh (1978); 1985; 57(3):40-4. PubMed ID: 2411040
[TBL] [Abstract][Full Text] [Related]
10. [Combined use of terrilytin, sodium salicylate and heparin for the purpose of regulating hemostasis].
Mamedov IaD; Reĭsh AV
Probl Gematol Pereliv Krovi; 1981 May; 26(5):52-5. PubMed ID: 6166936
[No Abstract] [Full Text] [Related]
11. Non-productive activation of the proteinase binding sites of alpha 2-macroglobulin on reaction of the inhibitor with matrix-linked trypsin.
Björk I
Biochem Biophys Res Commun; 1984 Jan; 118(2):691-5. PubMed ID: 6200107
[TBL] [Abstract][Full Text] [Related]
12. Proteases and protease inhibitors in cerulein-induced acute pancreatitis in rats.
Kruse P; Lasson A; Hage E
J Surg Res; 1999 Aug; 85(2):294-300. PubMed ID: 10423332
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study of the antiproteinase activity of human alpha-2-macroglobulin concentrate].
Belova TA; Khvatov VB; Merzlov VP
Vopr Med Khim; 1983; 29(4):22-7. PubMed ID: 6194617
[TBL] [Abstract][Full Text] [Related]
14. [Parameters of plasma blood proteolysis and phenotypes of alpha1-proteinase inhibitor in children with duodenal ulcer].
Akbasheva OE
Biomed Khim; 2007; 53(3):338-44. PubMed ID: 17722585
[TBL] [Abstract][Full Text] [Related]
15. Effect of serum alpha2-macroglobulin on the trypsin-soybean trypsin inhibitor complex.
Ganea D; Dumitrescu A; Szegli G
Arch Roum Pathol Exp Microbiol; 1974; 33(3-4):325-33. PubMed ID: 4143177
[No Abstract] [Full Text] [Related]
16. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
Lasson A; Dittmann B; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
[TBL] [Abstract][Full Text] [Related]
17. [Reactions between protease inhibitors in blood plasma and collagen].
Zorin NA; Zhabin SG; Kozlov IG; Gorlina NK; Iarovinskiĭ TO; Emel'ianov AIu; Semen'kov NN
Vopr Med Khim; 1995; 41(6):53-5. PubMed ID: 8619306
[TBL] [Abstract][Full Text] [Related]
18. [Main proteolytic inhibitors in ocular herpes].
Chesnokova NB; Kasavina BS; Maĭchuk IuF; Kazachenko MA; Shchipanova AI
Vopr Med Khim; 1981; 27(5):663-5. PubMed ID: 6171934
[TBL] [Abstract][Full Text] [Related]
19. [Serum antiprotease activity following parenteral administration of proteolytic enzymes, histamine and acetylcholine].
Protsenko VA; Bogadel'nikov IV; Spitsyn IF
Vopr Med Khim; 1978; 24(6):736-40. PubMed ID: 734973
[TBL] [Abstract][Full Text] [Related]
20. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
Lasson A; Ohlsson K
Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
